FDA Approved: BILTRICIDE — Supplemental Application (Bayer HealthCare Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for Biltricide (praziquantel) from Bayer HealthCare Pharmaceuticals, authorizing changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphyllobothriasis
• Hymenolepiasis
• Schistosomiasis
• Taeniasis

Drugs mentioned

• BILTRICIDE (praziquantel)

Snippet

SUPPL AP for BILTRICIDE (PRAZIQUANTEL)